Fagron’s Post

2024 Overseas Pharmaceutical Market Products and Trends Conference The guest speakers for this session include： Ms. Bree Wang, Vice President and General Manager of the Pharmaceutical Division at ECHEMI; Mr. Shimelis Birhanu, the General Manager of Ultra-Med Health Consulting Services; Mr. Helton Chang, CEO of Genohope Biotech. These three speakers will deliver presentations on topics such as the overview and development prospects of China's active pharmaceutical ingredient exports, analysis and regulatory requirements of the Ethiopian pharmaceutical market, and the challenges faced by CDMOs in the capital winter. They will provide valuable industry insights for the participants. In the rapid development and changes of the global pharmaceutical field, through cooperation and innovation, we can collectively address challenges, seek opportunities, and promote progress and development in the industry by CDMOs in the capital winter. They will provide valuable industry insights for the participants.

NEWS! Antheia, Inc., the pharmaceutical ingredient manufacturer transforming essential medicine supply chains and Olon Group, the global leader in developing and manufacturing active pharmaceutical ingredients  (APIs) for CDMO (contract development and manufacturing organization) and generic markets, today announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products. Antheia and Olon established this partnership in 2022 to leverage Olon’s fermentation sites across Italy. Olon has since played a pivotal role as a CDMO for scaling Antheia’s biomanufacturing processes and producing its Biosynthetic KSMs (key starting materials) and APIs. Looking to 2024 and beyond, Antheia will continue to partner with Olon to unlock additional capacity to meet international demand for its first products, including thebaine. Discover more here: https://lnkd.in/dwX4UN49 #news #cdmo #apis #partnership #biomanufacturing #pharma #biotech

Pharmaceutical Packaging Market Size to Hit US$ 269.9 billion in 2028 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲👉https://lnkd.in/divaF3H2 The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and projected to reach USD 269.9 billion in 2028, at a CAGR of 15.4%. The market growth is driven by increasing concerns about chronic diseases, driving the demand for packaging that ensures product integrity and minimizes contamination risks. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:👇 ☑️ Berry Global, Inc. ☑️ Gerresheimer ☑️ Amcor ☑️ SCHOTT ☑️ AptarGroup S.A. ☑️ BD ☑️ WestRock Company ☑️ Nipro Medical Corporation ☑️ Catalent Pharma Solutions ☑️ Sealed Air Corporation ☑️ West Pharmaceutical Services ☑️ ALPLA Group ☑️ Ardagh Group ☑️ CCL Industries ☑️ Frank Noe ☑️ Gaplast GmbH ☑️ Lonza ☑️ Mondi Group ☑️ Nolato ☑️ Origin Pharma Packaging ☑️ Comar ☑️ Bilcare Research ☑️ SGD Pharma ☑️ Silgan Holdings Inc. ☑️ VETTER PHARMA INTERNATIONAL, And So on...

Did you know AUROBINDO PHARMA LTD, a leading global pharmaceutical company, has a dedicated API (Active Pharmaceutical Ingredients) vertical - Apitoria?  Led by our esteemed CEO, Sanjay Chaturvedi, Apitoria Pharma Private Limited is built on a foundation of agility, reliability, and innovation. Our comprehensive API portfolio encompasses antibiotics, CNS & CVS, complex molecules, antidiabetics, oncology, and a vast array of additional offerings. Apitoria leverages a world-class infrastructure for API development and manufacturing.  This includes a state-of-the-art R&D Center and ten advanced manufacturing facilities. Collectively, these facilities deliver a robust installed API capacity of 18,000 MT, enabling the production of a diverse portfolio surpassing 250 molecules. Our unwavering commitment to global regulatory compliance is evidenced by our numerous filings.  This dedication, coupled with consistent supply of key input materials, rapid turnaround times, exceptional production capabilities, and global compliances, ensures we meet your every API need – reliably, from start to finish. Join our growing LinkedIn community to stay updated on: - The latest advancements in the API industry - Apitoria's commitment to quality and innovation - Insights from industry experts - Exclusive content and announcements Follow Apitoria Pharma Private Limited on LinkedIn today and be a part of the conversation! #Apitoria #AurobindoPharma #APIs #Pharmaceuticals #Innovation

We invite you to an engaging panel discussion on “Modern Control Strategies to Minimize Cross Contamination” at the 9th Global Pharmaceutical Quality Summit 2024. #Quality #Pharmaceuticals #Ecolab #contaminationcontrol #crosscontamination

Pharmaceutical Packaging Market Size to Hit US$ 269.9 billion in 2028 📚𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲👉https://lnkd.in/ds4KtGJ2 The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and projected to reach USD 269.9 billion in 2028, at a CAGR of 15.4%. The market growth is driven by increasing concerns about chronic diseases, driving the demand for packaging that ensures product integrity and minimizes contamination risks. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:👇 ☑️ Berry Global, Inc. ☑️ Gerresheimer ☑️ Amcor ☑️ SCHOTT ☑️ AptarGroup S.A. ☑️ BD ☑️ WestRock Company ☑️ Nipro Medical Corporation ☑️ Catalent Pharma Solutions ☑️ Sealed Air Corporation ☑️ West Pharmaceutical Services ☑️ ALPLA Group ☑️ Ardagh Group ☑️ CCL Industries ☑️ Frank Noeltgen ☑️ Gaplast GmbH ☑️ Lonza ☑️ Mondi Group ☑️ Nolato ☑️ Origin Pharma Packaging ☑️ Comar ☑️ Bilcare Research ☑️ SGD Pharma ☑️ Silgan Holdings Inc. ☑️ VETTER PHARMA INTERNATIONAL, And Others...

Pharmaceutical Packaging Market Size to Hit US$ 269.9 billion in 2028 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲👉https://lnkd.in/divaF3H2 The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and projected to reach USD 269.9 billion in 2028, at a CAGR of 15.4%. The market growth is driven by increasing concerns about chronic diseases, driving the demand for packaging that ensures product integrity and minimizes contamination risks. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:👇 ☑️ Berry Global, Inc. ☑️ Gerresheimer ☑️ Amcor ☑️ SCHOTT ☑️ AptarGroup S.A. ☑️ BD ☑️ WestRock Company ☑️ Nipro Medical Corporation ☑️ Catalent Pharma Solutions ☑️ Sealed Air Corporation ☑️ West Pharmaceutical Services ☑️ ALPLA Group ☑️ Ardagh Group ☑️ CCL Industries ☑️ Frank Noe Egypt Ltd ☑️ GAPLAST GmbH ☑️ Lonza ☑️ Mondi Group ☑️ Nolato ☑️ Origin Pharma Packaging ☑️ Comar ☑️ Bilcare Research ☑️ SGD Pharma ☑️ Silgan Holdings Inc. ☑️ VETTER PHARMA INTERNATIONAL, And SO on...

🌍 Building a Competitive & Innovative Pharmaceutical Ecosystem for the EU   As the EU looks ahead to the next decades, it's crucial to prepare the European pharmaceutical sector to tackle emerging challenges and seize new opportunities.    ✒️ By signing EUCOPE - European Confederation of Pharmaceutical Entrepreneurs’s open letter to the Presidents of the European Commission, European Parliament, and Council of the European Union, 24 EUCOPE members urge the EU Institutions and Member States to collaborate in creating a competitive and attractive pharmaceutical landscape. 🏥✨    🔬 To remain globally competitive, pharmaceutical companies need a robust, predictable and strong investment and industrial ecosystem.    💊  Special emphasis should be placed on small and mid-sized innovative companies, which are pivotal in driving technology and medical advancements across Europe.    #PharmaInnovation #EUPharma #InnovationEcosystem #RareDiseases    👓 Read the open letter here: 👉 https://lnkd.in/eCeJk8U5   Alexion Pharmaceuticals, Inc. Amgen Angelini Pharma AOP Health Biogen BioMarin Pharmaceutical Inc. Blueprint Medicines Chiesi Group Circius Pharma CSL Emergent BioSolutions Incyte Insmed Incorporated MENARINI Group Miltenyi Biomedicine MSD Norgine Orion Corporation Sanofi Santen Shionogi Europe Sobi - Swedish Orphan Biovitrum AB (publ) Takeda

How to solve the specific manufacturing challenges associated with small molecules Active Pharmaceutical Ingredients (APIs)? 💊 📅 Join our FREE webinar on October 2nd at 5 PM CET: "Conquering Manufacturing Challenges in Oncology: A Focus on Small Molecule APIs." Are you a pharmaceutical company developing innovative small molecule oncology drugs?  These complex molecules often require specialized expertise and capabilities in manufacturing. SEQENS is here to help. We've invested in cutting-edge facilities and our experienced team is committed to address the unique challenges associated with potent APIs such as the ones developed for oncology. In this webinar, you'll discover: ➡️How to manage low Occupational Exposure Limits for the manufacturing of Potent active ingredients and intermediates ➡️Case studies on handling potent chemicals: from lab scale to process industrialization ➡️Insights on our new capacities for manufacturing anticancer Active Pharmaceutical Ingredients, with highly potent and potent capabilities   I'll be one of the expert speakers sharing their insights: Nathalie ARGENTIN, Group Industrial Hygiene Expert Charles Guérin, Ph.D, Head of R&D Chemical Development – Innovative Charles BRIGATI, Process Engineer – Industrial Projects Ronan Rocle, Technology Marketing Manager Register now and secure your spot! ➡️ [https://lnkd.in/dpxe9Prg] #Seqens #OncologyAPIs #SmallMolecules #PharmaManufacturing #Webinar

ARE YOU INTERESTED IN HELPING THE SOCIETY FIGHT AGAINST GASTROINTESTINAL DISEASES? Make Proton Pump Inhibitor Active Pharmaceutical Ingredient Molecules. Why? Because Proton Pump Inhibitors are Active Pharmaceutical Ingredients. These active molecules give the Power to the Medicines to fight against Gastrointestinal Diseases. PROTON PUMP INHIBITOR MOLECULES Proton Pump Inhibitor Molecules inhibit stomach acid secretion. That’s how they’re effective in the treatment of peptic ulcer, gastroesophageal reflux diseases and other Gastrointestinal diseases. Some of the commercially important molecules in this category are: ☑ Omeprazole ☑ Pantoprazole ☑ Lansoprazole ☑ Rabeprazole ☑ Esomeprazole ☑ Dexlansoprazole However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to make the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #chemicalIndustry #pharmaceuticalIndustry #ActivePharmaceuticalIngredient   #PharmaceuticalBusiness #CardioVascularDisease  #GastrointestinalMedication #GastrointestinalActivePharmaceuticalIngredient #ProtonPumpInhibitor #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur